Mack Anthony P. 4/A
4/A · Virpax Pharmaceuticals, Inc. · Filed Feb 7, 2023
Insider Transaction Report
Form 4/AAmended
Mack Anthony P.
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2023-01-25+125,000→ 125,000 totalExercise: $0.87Exp: 2028-01-25→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal annual installments commencing on January 25, 2024.